108 related articles for article (PubMed ID: 7678032)
1. Allergen-specific modulation of cytokine synthesis patterns and IgE responses in vivo with chemically modified allergen.
Gieni RS; Yang X; HayGlass KT
J Immunol; 1993 Jan; 150(1):302-10. PubMed ID: 7678032
[TBL] [Abstract][Full Text] [Related]
2. Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Gieni RS; Yang X; Kelso A; Hayglass KT
Immunology; 1996 Jan; 87(1):119-26. PubMed ID: 8666423
[TBL] [Abstract][Full Text] [Related]
3. Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin.
Hayglass KT; Gieni RS; Stefura WP
Immunology; 1991 Aug; 73(4):407-14. PubMed ID: 1717367
[TBL] [Abstract][Full Text] [Related]
4. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production.
Rempel JD; Wang M; HayGlass KT
J Immunol; 1997 Aug; 159(3):1490-6. PubMed ID: 9233648
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific modulation of murine IgE and IgG2a responses with glutaraldehyde-polymerized allergen is independent of MHC haplotype and Igh allotype.
Hayglass KT; Stefura W
Immunology; 1991 May; 73(1):24-30. PubMed ID: 1710602
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific inhibition of ongoing murine IgE responses. II. Inhibition of IgE responses induced by treatment with glutaraldehyde-modified allergens is paralleled by reciprocal increases in IgG2a synthesis.
Hayglass KT; Stefura WP
J Immunol; 1991 Oct; 147(8):2455-60. PubMed ID: 1717560
[TBL] [Abstract][Full Text] [Related]
7. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization.
Renz H; Lack G; Saloga J; Schwinzer R; Bradley K; Loader J; Kupfer A; Larsen GL; Gelfand EW
J Immunol; 1994 Jan; 152(1):351-60. PubMed ID: 8254203
[TBL] [Abstract][Full Text] [Related]
9. Modulation of antigen-induced B and T cell responses by antigen-specific IgE antibodies.
Oshiba A; Hamelmann E; Haczku A; Takeda K; Conrad DH; Kikutani H; Gelfand EW
J Immunol; 1997 Oct; 159(8):4056-63. PubMed ID: 9378995
[TBL] [Abstract][Full Text] [Related]
10. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
11. Anti-interferon gamma treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses.
HayGlass KT; Stefura BP
J Exp Med; 1991 Feb; 173(2):279-85. PubMed ID: 1703203
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the human IgE response.
de Vries JE; Yssel H
Eur Respir J Suppl; 1996 Aug; 22():58s-62s. PubMed ID: 8871045
[TBL] [Abstract][Full Text] [Related]
13. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice.
Lack G; Bradley KL; Hamelmann E; Renz H; Loader J; Leung DY; Larsen G; Gelfand EW
J Immunol; 1996 Aug; 157(4):1432-9. PubMed ID: 8759723
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
Wang M; Ellison CA; Gartner JG; HayGlass KT
J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
[TBL] [Abstract][Full Text] [Related]
15. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of primary and recall allergen-specific T helper cell type 2-mediated responses by a T helper cell type 1 stimulus.
Scott DE; Agranovich I; Inman J; Gober M; Golding B
J Immunol; 1997 Jul; 159(1):107-16. PubMed ID: 9200445
[TBL] [Abstract][Full Text] [Related]
18. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease.
Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E
Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
